(NasdaqGM:RAAQU),(NasdaqGM:RAAQW),(NasdaqGM:RAAQ), PRINCETON, NEW JERSEY, May 29, 2025 (GLOBE NEWSWIRE) — Real Asset Acquisition Corp. (Nasdaq: RAAQU) (the “Company”) announced that holders of the units sold in the Company's initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriters of their overallotment option in full, completed on April […]

(NasdaqGM:FULC), CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced upcoming presentations at the 5th Global Congress on Sickle Cell Disease and the 2025 European Hematology Association

Digital Asset Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 2, 2025 GlobeNewswire May 29, 2025 PRINCETON, NEW JERSEY, May 29, 2025 (GLOBE NEWSWIRE) — Digital Asset Acquisition Corp. (Nasdaq: DAAQU) (the “Company”) announced that holders of the units sold in the Company's initial

Real Asset Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 2, 2025 GlobeNewswire May 29, 2025 PRINCETON, NEW JERSEY, May 29, 2025 (GLOBE NEWSWIRE) — Real Asset Acquisition Corp. (Nasdaq: RAAQU) (the “Company”) announced that holders of the units sold in the Company's initial

Fulcrum Therapeutics to Present at Upcoming Medical Meetings GlobeNewswire May 29, 2025 CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.(R) (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced upcoming presentations at the 5th Global

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ:VTRS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Viatris, you are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE:OGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Organon you are

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Iovance you are

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Resources, Inc. (NYSE:CIVI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Civitas you are

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE:BBAI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in BigBear.ai, you are